Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
BioSerenTach Logo
BioSerenTach CB Rank
2197621
Heat Score
48
BioSerenTach Inc delivers antigens directly to Langerhans cells of the immune system.
Founded
obfuscation
Private Kyoto, Kyoto, Japan www.bioserentach.co.jp/
Biotechnology
Health Care
Overview

BioSerenTach
Heat Score
48

Growth Score
pts
in past quarter
Heat Score 48
-11 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About BioSerenTach

CB Rank
2197621
BioSerenTach Inc delivers antigens directly to Langerhans cells of the immune system.
Founded
obfuscation
Private Kyoto, Kyoto, Japan www.bioserentach.co.jp/
Biotechnology
Health Care

Key People

Details

Legal Name BioSerenTach Inc
Also Known As 株式会社BioSerenTach
Operating Status Active
Company Type For Profit
Phone Number 075-746-2160
Contact Email info@bioserentach.co.jp
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Self-dissolving Microneedle Array Chip
A microneedle patch that delivers antigens directly to Langerhans cells by penetrating the skin and dissolving to release the payload.
Gastrointestinal Mucoadhesive Patch System (GI-MAPS)
A patch system that adheres to the gastrointestinal mucosa to deliver drugs or antigens locally within the GI tract.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Employee Profiles 1

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

60

Active Website Tech Count

9BioSerenTach is actively using 9 technologies for its website, according to BuiltWith. These include SPF, Apache, and  DMARC.

Total IP

15The intellectual property of BioSerenTach includes 15 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is BioSerenTach's headquarters? BioSerenTach is located in Kyoto, Kyoto, Japan.Who are BioSerenTach's competitors? Alternatives and possible competitors to BioSerenTach may include Hemostod, DecImmune Therapeutics, and  Universal Stabilization Technologies.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|